We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | 11.00 | 12.00 | 11.50 | 11.50 | 11.50 | 211,810 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.86M | -0.0063 | -18.25 | 106.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/11/2024 13:33 | you are so wrong Lozan Private investors are increasing there holdings and new investors are stepping in .. what you have missed is the huge number of shares absorbed from Calculus on the back of that RNS data we may see more selling up by that fund we now have no idea of how many they have but it will stop .... Scancell has given no reason yet to sell ..... but we do have 2 experts Burble and Bermuda ... who have been ignored they both have stated they will not buy currently the market actually thinks different .... time will tell | inanaco | |
22/11/2024 13:06 | Ignored.... AGAIN - Some might care to check the chart for the last week or so. . A reminder = . the real lozan - 14 Nov 2024 - 10:55:28 - 14036 of 14691 Scancell - Pot of Gold or POS? - SCLP Don't suppose there are,yet again, all the signs in place today for the unwary to get SPIKED ??? Again Some folks have yet to learn Some folks will never learn | the real lozan | |
22/11/2024 12:28 | take a ship ... lets say you pick up the missile at 100 miles the missile is travelling at 8439.96 mph under a second its hit you Phalanx CIWS Wikipedia › wiki › Phalanx_CIWS Phalanx CIWS ; 150° from either side of centerline · 4,500 rounds/minute (75 rounds/second) its only effective at 1500m rather than the missile facing a wall of lead its facing just a few bullets all your capital ships are now at Risk .... like i said .............. lets hope somebody has the maths wrong mach 11 | inanaco | |
22/11/2024 12:08 | well SC102 ... this missile is a game changer .... its like putting a glider against a jet fighter Nato to discuss new Russian missile Nato and Ukraine will hold talks next week in Brussels over Russia’s firing of an experimental hypersonic intermediate-range missile. Ambassadors from countries in the Nato-Ukraine Council will meet on Tuesday to discuss the strike on the city of Dnipro. A spokeswoman for Nato said: “Deploying this capability will neither change the course of the conflict nor deter Nato allies from supporting Ukraine.” | inanaco | |
22/11/2024 12:02 | Here are some examples of bullet muzzle velocities: Handguns and sub-machine guns: Low velocity (LV) bullets with muzzle velocities of 200–500 m/s Rifles, carbines, and machine guns: HV bullets with muzzle velocities of 650–1,000 m/s Modern rifles with high-velocity cartridges: Muzzle velocities of more than 1,200 m/s Tank guns firing kinetic energy penetrator ammunition: Muzzle velocities of up to 1,700 m/s | inanaco | |
22/11/2024 11:51 | that is seriously quick you would have to intercept as it came towards you just a few seconds to target how could you chase that ? patriot would not get a look in | inanaco | |
22/11/2024 11:47 | New Russian missile flew at eleven times the speed of sound, says Ukraine The experimental Russian mid-range ballistic missile that struck the Ukrainian city of Dnipro on Thursday reached a top speed beyond Mach 11, Kyiv’s top spy agency said. A speed of Mach 11, which is more than 13,500km/h, would classify the new missile as faster than hypersonic, which ranges from 5 to 10 Mach, reaching the high-hypersonic qualification. “The flight time of this Russian missile from the moment of its launch in the Astrakhan region to its impact in the city of Dnipro was 15 minutes,” the Main Directorate of Intelligence said in a statement, adding that the weapon was likely from the ‘Kedr’ missile complex. “The missile was equipped with six warheads: Each equipped with six submunitions. The speed at the final part of the trajectory was over Mach 11.” | inanaco | |
22/11/2024 11:23 | With the PMI now dropping below 50 ...... UK Wealth is pulling up the draw bridge there will only be one winner .... and it will not be the Labour Party One woman on Question Time last night "you don't appear to know what you are doing" biggest clap of the event perhaps Baby Buffet can explain | inanaco | |
22/11/2024 11:15 | You guys have your own "talk to yourself Channel" why not post on that one ? | inanaco | |
22/11/2024 09:05 | Just look at what you do Sci102. You're in a losing position in a stock you falsely criticise for getting it all wrong yourself...in hindsight. You make up stories which are pointless because your premise is all wrong anyway. All the evidence tells you this but you don't accept it. You make up more stories. Does basket&case come to mind ? Lol | 2tyke | |
22/11/2024 08:45 | On the contrary, you are the one showing up after the fact. Now go exchange fantasy stories with inan and pretend together that you can "teach" anything all. | sci102 | |
22/11/2024 08:41 | You can lead an horse to water.... I could tell you the exact corrective and impulse patterns the stock is showing but they'd mean nothing to you obviously. With your attitude you'll always be behind the curve...making things up....kidding yourself ...in hindsight. Never anticipating correctly....in advance............. Bitcoin still closing in on $100k | 2tyke | |
22/11/2024 08:29 | You are a delusional fool tyke, no better than the other ones. Shut up already with your elliott snakeoil. | sci102 | |
22/11/2024 08:24 | Sci102, There is nothing wrong with the news flow from the company whatsoever....or a he communication. The progress looks excellent on all fronts. I think you need to stop thinking that would be investors are all mad keen scientific types that analyse every detail for exact clinical efficacy..they aren't. Neither do big investors make any difference to a stock price if they want to get involved. They either negotiate a tranche direct from the company if they are an institution....or they mop up sellers and weak holders if not. What your missing is that the share price moves simply just don't depend on outside events. That really should be obvious by now if you claim to follow markets. Stop trying to put your hindsight biased interpretations on the price movements. Investors simply try to make a profit or mitigate a loss. They do similar things at similar points in time and tend to follow the lead of others by herding. Sentiment cycles from bullish to bearish. The price dropped on the recent RNS simply because the recent bounce higher was complete at 18p. Nothing more sinister than that. The market is a place of irony...and contradiction. | 2tyke | |
22/11/2024 08:19 | It’s not that mad Gazza, it’s possible It all depends if someone takes on scib as a partner with them paying up front and the trials. Also if SC134 hits a large up front. Some think positive data over the next 6 months will see an acquisition. 3 ORR head and neck tells is the modi combo works. So a fair chance it’s working in renal too, which is the main event there so far. As head and neck has past Simon stage 1 it must be performing better than the standard of care. | chilltime | |
22/11/2024 07:53 | It isn't that the markets don't understand SC. It's that SC doesn't understand the markets. As I said before, LD treated investors as if they were charity supporters from the general public. Except the fools in these forums, investors are not the general public. "Sci102 - 19 Jun 2024 - 11:46:00 - 424 of 553 The share price did not react further and instead fell back to the pre RNS levels because the CEO f-ed up the interview by assuming that investors are the same as the general public that visits her academic lab to hear from the scientists how expensive is what they are doing and how they could use more support/donations. High profile investors that could have made a difference are not the general public ffs, when you tell them that scib1 recruitment was slow because people were waiting for iscib1+, they are neither impressed nor amused. They take it as a straight lie, because it is. And that is on top of all the other lies she said before. Sadly after 20 years, she still does not understand how to run a public company and she should either quit the CEO position or at least get some training." | sci102 | |
22/11/2024 05:01 | Just a couple of reminders "Sci102 - 12 Jan 2024 - 16:30:06 - 12 of 450 Scancell investors thread (litter free) - SCLP My issue isn't w avidimab, it's that we shouldn't put too much weight on iSCBI1+ in the short term. This is because we don't know how the new epitopes are going to work exactly and if further changes will be necessary. This is both from the point of view of safety (that's why the regulator asked for more data) and efficacy in the expanded population. If all goes smoothly, grest. But if it needs more work, that's not a disaster either. SCIB1 already has great value potential for this company and investors. It is more important to secure a partnership and it can happen with or without the current version of iSCIB1+ performing as expected. Now we risk finding ourselves in a position where SCIB1 works great, but iSCIB1+ disappoints to some extend, which means if we need to raise cash to move forward this will be done at much lower pps than it would be the case with SCIB1 data alone. While they could only report on SCIB1 in the next period, investors already expect iSCIB1+ data, so the same applies. In other words, they now need both of them to be great in order to raise cash at a greatly higher pps, while with a proper communication strategy since Nov 2023, they would only need 1 that already had supportive data anyway." "Sci102 25 Sep '24 - 07:03 - 511 of 550 Edit PS they now want to change the narrative from 85% to >70%. They should have done that months ago, keeping (future) investors and analysts engaged while setting up the narrative to maximise the benefit of the (hopefully) good final(ish) results. Now they are risking a lukewarm response to objectively good results. Amateurs" PS I think the BoD asked LD to clean up her mess before the new CEO, CMO etc start to front the communication. Starting to report closer to the protocol was a step forward in that direction. Not there yet though, as the new CEO would have addressed investors via an interview already. In fact neither the CEO nor the CMO (the head of clinical development) provided a comment in the latest RNS. You can't bang a drum that is out of tune... | sci102 | |
21/11/2024 21:20 | Lol gazza... Yes these little biotech stocks do tend to be diluted to confetti. The institutions play with them to make some money. PI's usually get slaughtered. | 2tyke | |
21/11/2024 21:10 | Even more unbelievable, there are some who think there will only be 1 billion Scancell shares ever issued. | gazza | |
21/11/2024 20:47 | Bitcoins are very rare... Only ever be 21 million and over 19 million already mined. Digital gold ....but much better than gold ! | 2tyke | |
21/11/2024 19:57 | bitcoins must be rare .. mind you i have never seen one oh well, will keep watching antiques roadshow | inanaco | |
21/11/2024 16:32 | Yes that's right.... Big breakthroughs generally accompanied by falling stock prices. Never mind....Bitcoin closing in on $100k. | 2tyke | |
21/11/2024 16:09 | Lindy on Proactive:HTTps://ww | pharmaboy3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions